Inverness Medical Innovations, Inc. Announces Offering of $150 Million of Se...( WALTHAM Mass. Aug. 4 /- Inverne...),Health

WALTHAM, Mass., Aug. 4 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE: IMA), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, today announced that it intends to offer $150 million of senior notes due 2016 in a public offering. Payment of the notes will be guaranteed by certain of Inverness' domestic subsidiaries. Inverness intends to use the net proceeds from the offering solely to fund its previously announced acquisition of Concateno plc, which the Company expects to close on or about August 11, 2009.

Jefferies & Company, Inc., Goldman, Sachs & Co. and Well Fargo Securities, LLC will act as joint book-running managers for the offering.

The offering will be made under Inverness' shelf registration statement on Form S-3 filed with the SEC on April 10, 2009 and amended on August 4, 2009. Inverness intends to file with the SEC later today a preliminary prospectus supplement and accompanying prospectus for the offering to which this communication relates. Before you invest, you should read the preliminary prospectus supplement, the accompanying prospectus, and the other documents we have filed with the SEC for more complete information about us and the offering. You may obtain these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, a copy of the preliminary prospectus supplement and accompanying prospectus may be obtained from Jefferies & Company, Inc. at One Station Place, Three North, Stamford, CT 06902, Attention: Timothy Lepore or at 1-888-708-5831, from Goldman, Sachs & Co. at 85 Broad Street, New York, NY 10004, Attention: Prospectus Department, or at 1-866-471-2526, or Wells Fargo Securities, LLC at 301 South College Street, Sixth Floor, Charlotte,
'/>"/>